GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 957.5 GBX 0.08% Market Closed
Market Cap: £79.6B

Balance Sheet

Balance Sheet Decomposition
GlaxoSmithKline PLC

Balance Sheet
GlaxoSmithKline PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
1 052
962
1 161
686
620
627
652
856
1 027
841
1 465
2 549
1 313
1 114
1 462
826
569
795
1 762
1 427
879
2 746
3 693
3 150
Cash
0
0
0
686
620
627
652
856
1 027
841
1 465
2 549
1 313
1 114
1 462
826
569
795
1 762
1 427
879
748
943
761
Cash Equivalents
1 052
962
1 161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 998
2 750
2 389
Short-Term Investments
1 417
2 657
2 971
4 548
2 420
3 905
5 362
5 957
5 214
5 057
2 800
3 051
3 094
4 791
3 524
3 085
3 389
3 991
4 608
2 908
6 998
2 246
21
9
Total Receivables
4 378
4 759
4 756
5 298
5 199
5 314
6 046
6 248
5 591
5 320
5 060
5 281
4 449
5 488
5 917
5 950
6 322
7 148
7 264
8 031
7 115
7 403
6 935
7 374
Accounts Receivables
3 515
3 715
3 786
4 411
4 356
4 649
5 333
5 486
4 727
4 441
4 115
3 966
3 556
3 879
4 679
4 693
5 185
5 494
5 562
6 261
5 473
5 976
5 582
5 928
Other Receivables
863
1 044
970
887
843
665
713
762
864
879
945
1 315
893
1 609
1 238
1 257
1 137
1 654
1 702
1 770
1 642
1 427
1 353
1 446
Inventory
2 080
2 109
2 192
2 177
2 437
3 062
4 056
4 064
3 837
3 873
3 969
3 900
4 231
4 716
5 102
5 557
5 476
5 947
5 996
5 783
5 146
5 498
5 669
5 924
Other Current Assets
1 822
2 138
2 553
468
316
718
1 153
445
367
1 076
398
446
1 591
478
706
489
1 171
1 610
617
525
631
751
679
1 053
Total Current Assets
10 749
12 625
13 633
13 177
10 992
13 626
17 269
17 570
16 036
16 167
13 692
15 227
14 678
16 587
16 711
15 907
16 927
19 491
20 247
18 674
20 769
18 644
16 997
17 510
PP&E Net
6 649
6 441
6 471
6 652
6 930
7 821
9 678
9 374
9 045
8 748
8 776
8 872
9 052
9 668
10 808
10 860
11 058
11 314
11 006
10 672
9 620
9 957
10 073
10 048
PP&E Gross
6 649
6 441
6 471
6 652
6 930
7 821
9 678
9 374
9 045
8 748
8 776
8 872
9 052
9 668
10 808
10 860
11 058
11 314
11 006
10 672
9 620
9 957
10 073
10 048
Accumulated Depreciation
5 734
5 963
6 398
6 538
6 513
7 266
9 309
9 383
9 850
10 084
9 966
9 981
10 303
11 082
11 356
10 859
11 430
11 251
11 307
10 846
10 518
10 259
10 483
10 892
Intangible Assets
1 637
1 697
2 003
3 383
3 293
4 456
5 869
8 183
8 532
7 802
10 161
9 283
8 320
16 672
18 776
17 562
17 202
30 955
29 824
30 079
14 318
14 768
15 515
16 748
Goodwill
171
143
139
696
758
1 370
2 101
3 361
3 606
3 754
4 359
4 205
3 724
5 162
5 965
5 734
5 789
10 562
10 597
10 552
7 046
6 811
6 982
7 018
Note Receivable
0
0
0
0
0
432
540
560
533
505
558
559
642
732
886
875
816
893
858
935
965
950
1 044
1 033
Long-Term Investments
3 121
3 069
332
638
736
846
1 030
1 349
1 792
1 150
1 366
1 525
1 454
1 462
1 248
1 101
1 558
2 151
3 424
2 214
1 541
1 192
1 196
1 126
Other Long-Term Assets
0
0
0
2 652
2 844
2 452
2 906
2 465
2 686
2 954
2 563
2 415
2 781
3 163
4 687
4 342
4 716
4 326
4 475
5 977
5 887
6 683
7 656
7 635
Other Assets
171
143
139
696
758
1 370
2 101
3 361
3 606
3 754
4 359
4 205
3 724
5 162
5 965
5 734
5 789
10 562
10 597
10 552
7 046
6 811
6 982
7 018
Total Assets
22 327
N/A
23 975
+7%
22 578
-6%
27 198
+20%
25 553
-6%
31 003
+21%
39 393
+27%
42 862
+9%
42 230
-1%
41 080
-3%
41 475
+1%
42 086
+1%
40 651
-3%
53 446
+31%
59 081
+11%
56 381
-5%
58 066
+3%
79 692
+37%
80 431
+1%
79 103
-2%
60 146
-24%
59 005
-2%
59 463
+1%
61 118
+3%
Liabilities
Accounts Payable
715
686
707
819
865
931
1 153
1 855
2 141
2 568
2 666
2 739
2 790
3 120
3 596
3 528
3 645
4 144
4 357
4 535
3 866
3 717
3 462
3 535
Accrued Liabilities
3 372
3 229
3 224
3 877
3 654
3 668
4 586
4 481
4 381
4 449
4 345
4 505
4 700
5 324
6 444
6 929
8 535
9 111
9 753
11 186
10 587
10 711
10 367
10 433
Short-Term Debt
1 284
836
830
1 200
718
2 064
0
0
0
0
0
1 843
2 915
435
1 426
765
4 420
5 020
1 145
802
1 639
1 006
762
1 392
Current Portion of Long-Term Debt
267
616
752
0
0
1 440
956
1 471
291
2 698
3 631
946
28
873
2 703
2 060
1 373
1 898
2 580
2 799
2 313
1 807
1 587
1 620
Other Current Liabilities
3 170
3 230
3 209
3 615
2 028
2 242
3 322
4 311
5 981
5 295
3 173
3 644
2 862
3 665
4 832
13 287
4 518
3 877
4 313
4 348
4 405
3 827
5 519
4 411
Total Current Liabilities
8 808
8 597
8 722
9 511
7 265
10 345
10 017
12 118
12 794
15 010
13 815
13 677
13 295
13 417
19 001
26 569
22 491
24 050
22 148
23 670
22 810
21 068
21 697
21 391
Long-Term Debt
3 092
3 651
4 381
5 271
4 772
7 067
15 231
14 786
14 809
12 203
14 671
15 456
15 841
15 324
14 661
14 264
20 271
23 590
23 425
20 572
17 035
15 205
14 637
14 708
Deferred Income Tax
742
606
0
569
595
887
714
645
707
822
1 004
693
445
1 522
1 934
1 396
1 156
3 810
3 600
3 556
289
311
382
291
Minority Interest
807
745
277
259
262
307
387
737
858
795
937
815
673
3 764
3 839
3 557
688
6 952
6 221
6 287
502
552
585
421
Other Liabilities
2 297
2 656
3 273
4 277
3 273
2 794
5 113
4 571
4 175
4 218
5 238
4 448
6 134
14 305
18 522
10 663
10 476
9 885
10 450
9 963
9 916
9 626
9 661
8 772
Total Liabilities
15 746
N/A
16 255
+3%
16 653
+2%
19 887
+19%
16 167
-19%
21 400
+32%
31 462
+47%
32 857
+4%
33 343
+1%
33 048
-1%
35 665
+8%
35 089
-2%
36 388
+4%
48 332
+33%
57 957
+20%
56 449
-3%
53 706
-5%
68 287
+27%
65 844
-4%
64 048
-3%
49 548
-23%
45 658
-8%
45 792
+0%
44 741
-2%
Equity
Common Stock
1 506
1 487
1 484
1 491
1 498
1 503
1 415
1 416
1 418
1 387
1 349
1 336
1 339
1 340
1 342
1 343
1 345
1 346
1 346
1 347
1 347
1 348
1 348
1 349
Retained Earnings
4 851
5 969
4 137
5 271
7 030
6 834
6 646
8 343
6 801
5 400
2 735
3 021
55
732
3 263
4 348
8
6 659
8 884
10 073
6 492
9 368
9 925
12 338
Additional Paid In Capital
224
264
304
549
858
1 266
1 326
1 368
1 428
1 673
2 022
2 595
2 759
2 831
2 954
3 019
3 091
3 174
3 281
3 301
3 440
3 451
3 473
3 498
Unrealized Security Profit/Loss
0
0
0
0
0
0
8
22
89
70
105
413
274
295
380
329
140
409
1 302
383
308
510
659
506
Other Equity
0
0
0
0
0
0
1 448
1 144
849
498
401
368
164
84
289
411
208
183
226
49
373
310
416
302
Total Equity
6 581
N/A
7 720
+17%
5 925
-23%
7 311
+23%
9 386
+28%
9 603
+2%
7 931
-17%
10 005
+26%
8 887
-11%
8 032
-10%
5 810
-28%
6 997
+20%
4 263
-39%
5 114
+20%
1 124
-78%
68
N/A
4 360
N/A
11 405
+162%
14 587
+28%
15 055
+3%
10 598
-30%
13 347
+26%
13 671
+2%
16 377
+20%
Total Liabilities & Equity
22 327
N/A
23 975
+7%
22 578
-6%
27 198
+20%
25 553
-6%
31 003
+21%
39 393
+27%
42 862
+9%
42 230
-1%
41 080
-3%
41 475
+1%
42 086
+1%
40 651
-3%
53 446
+31%
59 081
+11%
56 381
-5%
58 066
+3%
79 692
+37%
80 431
+1%
79 103
-2%
60 146
-24%
59 005
-2%
59 463
+1%
61 118
+3%
Shares Outstanding
Common Shares Outstanding
6 024
5 949
5 693
5 653
5 756
5 508
5 058
5 191
5 196
5 049
4 903
4 855
4 864
4 870
3 928
3 966
3 938
3 963
4 024
4 025
4 034
4 056
4 145
4 075
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett